MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-18-0056406
S. Parikh Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹165.85 Cr
▼ 6% YoY
Net profit · FY 2024
₹1.57 Cr
Net margin 0.9%
EBITDA · FY 2024
₹2.93 Cr
EBITDA margin 1.8%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹45.25 Lakh
Issued & subscribed
Open charges
₹11.6 Cr
Satisfied ₹10.1 Cr
Company age
18 yrs
Est. 2008
Employees · EPFO
77
Provident fund records
About S. Parikh Pharma Private Limited
Data last updated:
S. Parikh Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 October 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2008PTC187415. Its GSTIN is 27AAMCS4654B1ZA (Maharashtra).
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹45.25 Lakh. It is led by directors including Bhaumik Rohit Shah and Nikesh Shailesh Parekh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹165.85 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹1.57 Cr (net margin 0.9%) and EBITDA of ₹2.93 Cr (EBITDA margin 1.8%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 3% over five years.
The company has about 77 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: S Parikh Pharma. As per MCA filings, the company has open charges of ₹11.6 Cr and satisfied charges of ₹10.1 Cr on record. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it; 1 case is pending. The company has 6 deals on record (5 secondary share transfers, 1 funding round), with disclosed funding of ₹44.2 Lakh; the latest was in January 2020.
S. Parikh Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0056406). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sparikh.co.in.
Company details
CIN U74999MH2008PTC187415
Registration Number 187415
Incorporation Date 10 October 2008
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-18-0056406
Recognitions & Rankings of S. Parikh Pharma
Contact details
S. Parikh Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is sparikh.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address1st Floor Gala No. 6 Hitex Industrial Estate Behind Petrol Pump S.V. Road Dahisar E, Ast, Mumbai, Maharashtra, India – 400068
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of S. Parikh Pharma Private Limited, buy the company report.
Comprehensive company report
S. Parikh Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
S. Parikh Pharma operates one associated brand: S Parikh Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical distribution, medical supplies, and healthcare services in India. | sparikh.co.in |
Business activity
The main business activity of S. Parikh Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of S. Parikh Pharma Private Limited, buy the company report.
Financials of S. Parikh Pharma Private Limited
FY 2024 filings availableS. Parikh Pharma Private Limited reported revenue of ₹165.85 Cr (down 6% YoY) for FY 2024.
Revenue · FY 2024
₹165.85 Cr ▼ 6%
Net profit · FY 2024
₹1.57 Cr margin 0.9%
EBITDA · FY 2024
₹2.93 Cr margin 1.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 6%
3 years · compounded
▲ 3%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▲ 1%
3 years · compounded
▼ 7%
5 years · compounded
▼ 1%
Revenue fell 6% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.93 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.57 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.8% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of S. Parikh Pharma Private Limited, buy the company report.
Board of directors of S. Parikh Pharma Private Limited
S. Parikh Pharma has 5 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhaumik Rohit Shah | Director | 16 Apr 2009 | 17 Years 6 Months | Current |
| Nikesh Shailesh Parekh Also directs: Suparshva Pharma Private Limited, Hiniss Consumer Private Limited | Director | 16 Mar 2018 | 8 Years 7 Months | Current |
| Nemish Shah Rajesh | Director | 05 Sep 2011 | 15 Years 1 Months | Current |
| Ashwin Mehta Shantilal Also directs: Suparshva Pharma Private Limited | Director | 16 Apr 2009 | 17 Years 6 Months | Current |
| Ankit Hemant Shah Also directs: Suparshva Pharma Private Limited | Director | 18 Feb 2016 | 10 Years 8 Months | Current |
Auditor
S. Parikh Pharma Private Limited is audited by SANDIP V. DOSHI & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANDIP V. DOSHI & CO. | FY 2023 | 115175W |
Shareholding
The shareholding of S. Parikh Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of S. Parikh Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹11.6 Cr
Satisfied charges
₹10.1 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Dec 2016 | 100075840 | The Hongkong and Shanghai Banking Corporation Limited | ₹10 Cr | Open | |
| 16 Dec 2016 | 100075841 | The Hongkong and Shanghai Banking Corporation Limited | ₹1.6 Cr | Open | |
| 16 Jun 2012 | 10368623 | Vasai Vikas Sahakari Bank Ltd | ₹4.5 Cr | Satisfied | |
| 24 Mar 2011 | 10278278 | The Royal Bank of Scotland N.V. | ₹2.6 Cr | Satisfied | |
| 08 Nov 2009 | 10185615 | Abn Amro Bank N.V. | ₹3 Cr | Satisfied |
To see the full charge records of S. Parikh Pharma Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
S. Parikh Pharma Private Limited has 6 deals on record (5 secondary share transfers, 1 funding round), with disclosed funding of ₹44.2 Lakh; the latest was in January 2020.
Total deals
6
Secondary share transfers
5
Funding round
1
Disclosed funding
₹44.2 Lakh
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Apr 2014 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jul 2010 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Raj-Vimal Financial Consultancy Private Limited , Nayanalin Chemicals LLP , an individual |
| Nov 2009 | Funding round | ₹44.2 Lakh | Investors: Nayanalin Chemicals LLP , 3 individuals |
To see the full deal history of S. Parikh Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
S. Parikh Pharma Private Limited has 3 court cases on record: 2 filed by S. Parikh Pharma, 1 filed against it. 1 case is pending and 2 are disposed.
Total cases
3
Filed by the company
2
Filed against the company
1
Pending
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 1 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Civil suit | Filed by the company against an individual | Pending |
| District court, Thane, Maharashtra | Civil suit | Filed against the company by an individual | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SS CASES S) | Filed by the company against an individual | Disposed |
To see the full case history of S. Parikh Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for S. Parikh Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
S. Parikh Pharma Private Limited has a workforce of 77 employees on its EPFO records as of Mar 29, 2024, across 1 active EPFO establishment.
Employee count
77
Active EPFO establishments
1
Employee growth
-47.62%
GST
S. Parikh Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAMCS4654B1ZA | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of S. Parikh Pharma Private Limited, buy the company report.
Recent activity
S. Parikh Pharma Private Limited has 14 board changes on record since 2009: 5 appointments and 9 cessations. The latest: Nikesh Shailesh Parekh ceased to be Additional Director on 30 Sep 2018.
AGM
S. Parikh Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
S. Parikh Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Ceased
Nikesh Shailesh Parekh ceased to be Additional Director.
Charges
A charge with The Hongkong And Shanghai Banking Corporation Limited of Rs. 10.00 Cr registered on 16 Dec 2016 with Charge ID 100075840 was modified on 22 May 2018.
Appointed
Nikesh Shailesh Parekh was appointed as Director.
Charges
A charge registered on 16 Jun 2012 via Charge ID 10368623 with Vasai Vikas Sahakari Bank Ltd was fully satisfied on 29 Mar 2017.
Charges
A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 1.60 Cr with Charge ID 100075841 was registered on 16 Dec 2016.
Charges
A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 10.00 Cr with Charge ID 100075840 was registered on 16 Dec 2016.
Ceased
Ankit Hemant Shah ceased to be Additional Director.
Appointed
Ankit Hemant Shah was appointed as Director.
Charges
A charge with Vasai Vikas Sahakari Bank Ltd of Rs. 4.50 Cr registered on 16 Jun 2012 with Charge ID 10368623 was modified on 19 Aug 2014.
Ceased
Hemant Popatlal Shah ceased to be Director.
16 earlier events are in the company report.
Frequently asked questions
S. Parikh Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 October 2008 (18+ years old) and is registered under CIN U74999MH2008PTC187415.
S. Parikh Pharma has 5 current directors:
- Bhaumik Rohit Shah - Director
- Nikesh Shailesh Parekh - Director
- Nemish Shah Rajesh - Director
- Ashwin Mehta Shantilal - Director
- Ankit Hemant Shah - Director
The latest financial statements of S. Parikh Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of S. Parikh Pharma is 27AAMCS4654B1ZA, registered in Maharashtra.
The CIN (Corporate Identification Number) of S. Parikh Pharma is U74999MH2008PTC187415. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
S. Parikh Pharma has 3 court cases on record: 2 filed by the company and 1 filed against it. 1 is pending.
S. Parikh Pharma was incorporated on 10 October 2008, making it 18+ years old. It is registered with the Registrar of Companies, Mumbai.
S. Parikh Pharma has 6 deals on record (5 secondary share transfers, 1 funding round), with disclosed funding of ₹44.2 Lakh; the latest was in January 2020.
Nikesh Shailesh Parekh ceased to be Additional Director on 30 Sep 2018. Nikesh Shailesh Parekh was appointed as Director on 16 Mar 2018. Ankit Hemant Shah ceased to be Additional Director on 30 Sep 2016. S. Parikh Pharma has 14 board changes on record in total.
Yes, S. Parikh Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-18-0056406).